All patients require long-term follow-up using periodic brain magnetic resonance imaging scans. Regular endocrinological follow-up is required in all patients with craniopharyngioma; ophthalmology follow-up postoperatively and at subsequent periodic intervals is also recommended.[8]Halac I, Zimmerman D. Endocrine manifestations of craniopharyngioma. Childs Nerv Syst. 2005 Aug;21(8-9):640-8.
https://link.springer.com/article/10.1007%2Fs00381-005-1246-x
http://www.ncbi.nlm.nih.gov/pubmed/16047216?tool=bestpractice.com
[21]Rajan B, Ashley S, Thomas DG, et al. Craniopharyngioma: improving outcome by early recognition and treatment of acute complications. Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):517-21.
http://www.ncbi.nlm.nih.gov/pubmed/9112447?tool=bestpractice.com
[24]Sorva R, Heiskanen O, Perheetupa J. Craniopharyngioma surgery in children: endocrine and visual outcome. Childs Nerv Syst. 1988 Apr;4(2):97-9.
http://www.ncbi.nlm.nih.gov/pubmed/3401877?tool=bestpractice.com
[49]Müller HL. Consequences of craniopharyngioma surgery in children. J Clin Endocrinol Metab. 2011 Jul;96(7):1981-91.
https://academic.oup.com/jcem/article/96/7/1981/2833879
http://www.ncbi.nlm.nih.gov/pubmed/21508127?tool=bestpractice.com
[50]Poretti A, Grotzer MA, Ribi K, et al. Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol. 2004 Apr;46(4):220-9.
http://onlinelibrary.wiley.com/doi/10.1111/j.1469-8749.2004.tb00476.x/pdf
http://www.ncbi.nlm.nih.gov/pubmed/15077699?tool=bestpractice.com
[64]Dekkers OM, Biermasz NR, Smit JW, et al. Quality of life in treated adult craniopharyngioma patients. Eur J Endocrinol. 2006 Mar;154(3):483-9.
https://eje.bioscientifica.com/view/journals/eje/154/3/1540483.xml
http://www.ncbi.nlm.nih.gov/pubmed/16498063?tool=bestpractice.com
Most patients are followed every 6 to 12 months, recognising that most recurrences occur relatively early (within the first several years). Patients with complications following treatment (hypothalamic syndrome, seizures, cognitive loss) may be followed on a more frequent basis. Patients are best managed by a multidisciplinary team, which may include a paediatrician or internist/primary care physician, endocrinologist, ophthalmologist, radiation oncologist, and neurosurgeon. Co-ordination of care may be challenging given the multiple specialties involved and is best managed at tertiary medical centres. Ideally, patients and families need a single contact person (physician or nurse), as care may seem fragmented and overly complicated. Having simple, direct lines of communication provides patients and families with a sense of continuity of care and improves care in a complex condition.